Monday, June 15, 2026

BLACKPINK Announces Long-Awaited Return with 2025 World Tour Teaser

BLACKPINK confirms their return with a 2025 World Tour announcement, igniting global fan excitement after their BORN PINK tour.

Kim’s Quiet Show of Force: North Korea Launches Missiles Amid Tensions

North Korea launched multiple short-range ballistic missiles without media coverage, likely to signal defiance amid rising tensions.

President Yoon’s G20 Agenda: A Focus on Ending Hunger and Climate Change

South Korean President Yoon Suk Yeol heads to Brazil for the G20 Summit, focusing on hunger eradication and sustainable development.

Tag: Cartistem

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.